1293950

Albert Wiegman — FEI 3040500587

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 13, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Amsterdam (Netherlands)

Additional Details

Clinical Investigator (CI)